These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24949429)

  • 1. Coexpression of SFRP1 and WIF1 as a prognostic predictor of favorable outcomes in patients with colorectal carcinoma.
    Huang S; Zhong X; Gao J; Song R; Wu H; Zi S; Yang S; Du P; Cui L; Yang C; Li Z
    Biomed Res Int; 2014; 2014():256723. PubMed ID: 24949429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation of SFRP1, SFRP2, and WIF1 and prognosis of postoperative colorectal cancer patients.
    Liu X; Fu J; Bi H; Ge A; Xia T; Liu Y; Sun H; Li D; Zhao Y
    BMC Cancer; 2019 Dec; 19(1):1212. PubMed ID: 31830937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of Wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma.
    Hu J; Dong A; Fernandez-Ruiz V; Shan J; Kawa M; Martínez-Ansó E; Prieto J; Qian C
    Cancer Res; 2009 Sep; 69(17):6951-9. PubMed ID: 19690140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The negative regulators of Wnt pathway-DACH1, DKK1, and WIF1 are methylated in oral and oropharyngeal cancer and WIF1 methylation predicts shorter survival.
    Paluszczak J; Sarbak J; Kostrzewska-Poczekaj M; Kiwerska K; Jarmuż-Szymczak M; Grenman R; Mielcarek-Kuchta D; Baer-Dubowska W
    Tumour Biol; 2015 Apr; 36(4):2855-61. PubMed ID: 25487617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of SFRP1 is a protumorigenic event in hepatoblastoma and correlates with beta-catenin mutations.
    Regel I; Eichenmüller M; Mahajan UM; Hagl B; Benitz S; Häberle B; Vokuhl C; von Schweinitz D; Kappler R
    J Cancer Res Clin Oncol; 2020 May; 146(5):1153-1167. PubMed ID: 32189106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Relevance of SFRP1 Gene Promoter Methylation in Colorectal Carcinoma.
    Kumar A; Gosipatala SB; Pandey A; Singh P
    Asian Pac J Cancer Prev; 2019 May; 20(5):1571-1577. PubMed ID: 31128064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent hypermethylation of WNT pathway genes in laryngeal squamous cell carcinomas.
    Paluszczak J; Hemmerling D; Kostrzewska-Poczekaj M; Jarmuż-Szymczak M; Grenman R; Wierzbicka M; Baer-Dubowska W
    J Oral Pathol Med; 2014 Oct; 43(9):652-7. PubMed ID: 24762262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Wnt antagonist sFRP1 in colorectal tumorigenesis.
    Caldwell GM; Jones C; Gensberg K; Jan S; Hardy RG; Byrd P; Chughtai S; Wallis Y; Matthews GM; Morton DG
    Cancer Res; 2004 Feb; 64(3):883-8. PubMed ID: 14871816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of secreted Wnt-antagonist genes hypermethylation in early detection of colorectal tumor].
    Qi J; Zhu YQ; Luo J; Tao WH
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(28):1954-7. PubMed ID: 17923031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Norcantharidin inhibits Wnt signal pathway via promoter demethylation of WIF-1 in human non-small cell lung cancer.
    Xie J; Zhang Y; Hu X; Lv R; Xiao D; Jiang L; Bao Q
    Med Oncol; 2015 May; 32(5):145. PubMed ID: 25814287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant promoter methylation of WIF-1 and SFRP1, 2, 4 genes in mesothelioma.
    Kohno H; Amatya VJ; Takeshima Y; Kushitani K; Hattori N; Kohno N; Inai K
    Oncol Rep; 2010 Aug; 24(2):423-31. PubMed ID: 20596629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low SFRP1 Expression Correlates with Poor Prognosis and Promotes Cell Invasion by Activating the Wnt/β-Catenin Signaling Pathway in NPC.
    Ren XY; Zhou GQ; Jiang W; Sun Y; Xu YF; Li YQ; Tang XR; Wen X; He QM; Yang XJ; Liu N; Ma J
    Cancer Prev Res (Phila); 2015 Oct; 8(10):968-77. PubMed ID: 26276746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional analyses and prognostic significance of SFRP1 expression in bladder cancer.
    Rogler A; Kendziorra E; Giedl J; Stoehr C; Taubert H; Goebell PJ; Wullich B; Stöckle M; Lehmann J; Petsch S; Hartmann A; Stoehr R
    J Cancer Res Clin Oncol; 2015 Oct; 141(10):1779-90. PubMed ID: 25732201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter methylation of Wnt antagonists DKK1 and SFRP1 is associated with opposing tumor subtypes in two large populations of colorectal cancer patients.
    Rawson JB; Manno M; Mrkonjic M; Daftary D; Dicks E; Buchanan DD; Younghusband HB; Parfrey PS; Young JP; Pollett A; Green RC; Gallinger S; McLaughlin JR; Knight JA; Bapat B
    Carcinogenesis; 2011 May; 32(5):741-7. PubMed ID: 21304055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter methylation of Wnt-antagonists in polypoid and nonpolypoid colorectal adenomas.
    Voorham QJ; Janssen J; Tijssen M; Snellenberg S; Mongera S; van Grieken NC; Grabsch H; Kliment M; Rembacken BJ; Mulder CJ; van Engeland M; Meijer GA; Steenbergen RD; Carvalho B
    BMC Cancer; 2013 Dec; 13():603. PubMed ID: 24350795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-339 and especially miR-766 reactivate the expression of tumor suppressor genes in colorectal cancer cell lines through DNA methyltransferase 3B gene inhibition.
    Afgar A; Fard-Esfahani P; Mehrtash A; Azadmanesh K; Khodarahmi F; Ghadir M; Teimoori-Toolabi L
    Cancer Biol Ther; 2016 Nov; 17(11):1126-1138. PubMed ID: 27668319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of WIF-1 and Wnt5a in patients with colorectal carcinoma: clinical significance.
    Abdelmaksoud-Dammak R; Miladi-Abdennadher I; Saadallah-Kallel A; Khabir A; Sellami-Boudawara T; Frikha M; Daoud J; Mokdad-Gargouri R
    Tumour Biol; 2014 Aug; 35(8):7975-82. PubMed ID: 24833087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Research progress of Wif1 in development of nervous system].
    Hu YA; Zhao CJ
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2010 Jan; 39(1):93-6. PubMed ID: 20175243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic silencing of sFRP1 activates the canonical Wnt pathway and contributes to increased cell growth and proliferation in hepatocellular carcinoma.
    Kaur P; Mani S; Cros MP; Scoazec JY; Chemin I; Hainaut P; Herceg Z
    Tumour Biol; 2012 Apr; 33(2):325-36. PubMed ID: 22351518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WIF1 re-expression in glioblastoma inhibits migration through attenuation of non-canonical WNT signaling by downregulating the lncRNA MALAT1.
    Vassallo I; Zinn P; Lai M; Rajakannu P; Hamou MF; Hegi ME
    Oncogene; 2016 Jan; 35(1):12-21. PubMed ID: 25772239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.